Association of macroalbuminuria with oxidized LDL and TGF-β in type 2 diabetic patients: A case-control study

International Urology and Nephrology

Volumn 42, Issue 2, 2010, Pages 487-492

  Nakhjavani, Manouchehr ^a   Esteghamati, Alireza ^a   Khalilzadeh, Omid ^a   Asgarani, Firouzeh ^a   Mansournia, Nasrin ^a   Abbasi, Mehrshad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Albuminuria; Diabetes mellitus; Diabetic nephropathy; Ox LDL; TGF

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; GLUCOSE; INSULIN; METFORMIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ALBUMINURIA; ARTICLE; ATTENUATION; BLOOD SAMPLING; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; URINARY EXCRETION;

ALBUMINURIA; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 77956181479     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9643-9     Document Type: Article

References (29)

1. Molitch ME, DeFronzo RA, Franz MJ et al (2004) Nephropathy in diabetes. Diabetes Care 27(Suppl 1): S79-S83
2. Wang SN, LaPage J, Hirschberg R (2000) Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int 57:1002-1014
3. Chen S, Iglesias-de la Cruz MC, Jim B, Hong SW, Isono M, Ziyadeh FN (2003) Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice. Biochem Biophys Res Commun 300:16-22
4. Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN (2001) The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy. Ren Fail 23:471-481
5. Russo LM, Osicka TM, Brammar GC, Candido R, Jerums G, Comper WD (2003) Renal processing of albumin in diabetes and hypertension in rats: possible role of TGFbeta1. Am J Nephrol 23:61-70
6. Russo LM, del Re E, Brown D, Lin HY (2007) Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor. Diabetes 56:380-388
7. Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN (1992) Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule. Kidney Int 41:107-114
8. Zhu Y, Usui HK, Sharma K (2007) Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment. Semin Nephrol 27:153-160
9. Song CY, Kim BC, Hong HK, Lee HS (2005) Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-beta signaling in mesangial cells. Kidney Int 67:1743-1752
10. Lan Y, Zhou Q, Wu ZL (2004) NF-kappa B involved in transcription enhancement of TGF-beta 1 induced by Ox- LDL in rat mesangial cells. Chin Med J (Engl) 117:225-230
11. Okada M, Takemura T, Yanagida H, Yoshioka K (2002) Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats. Kidney Int 61:113-124
12. Lee HS, Kim YS (1998) Identification of oxidized low density lipoprotein in human renal biopsies. Kidney Int 54:848-856
13. Takemura T, Yoshioka K, Aya N et al (1993) Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int 43:918-927
14. Grone HJ, Walli AK, Grone E, Kramer A, Clemens MR, Seidel D (1990) Receptor mediated uptake of apo B and apo E rich lipoproteins by human glomerular epithelial cells. Kidney Int 37:1449-1459
15. Song CY, Kim BC, Lee HS (2008) Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease inRas/extracellular signal-regulated kinase activity in mesangial cells. Transl Res 151:27-35
16. Lee HS, Song CY (2009) Oxidized low-density lipoprotein and oxidative stress in the development of glomerulosclerosis. Am J Nephrol 29:62-70
17. American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31(Suppl 1): S55-S60
18. Shin GT, Kim SJ, Ma KA, Kim HS, Kim D (2000) ACE inhibitors attenuate expression of renal transforming growth factor-beta1 in humans. Am J Kidney Dis 36:894-902
19. Langham RG, Kelly DJ, Gow RM et al (2006) Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibition. Diabetes Care 29:2670-2675
20. Chen S, Jim B, Ziyadeh FN (2003) Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 23:532-543
21. Gekle M, Knaus P, Nielsen R et al (2003) Transforming growth factor-beta 1 reduces megalin- and cubilin-mediated endocytosis of albumin in proximal-tubule-derived opossum kidney cells. J Physiol 552:471-481
22. Wolf G, Chen S, Ziyadeh FN (2005) From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54:1626-1634
23. Viswanathan V, Snehalatha C, Nair MB, Kumutha R, Ramachandran A (2005) Levels of transforming growth factor beta 1 in south Indian type 2 diabetic subjects. Diabetes Metab Res Rev 21:276-280
24. Nakhjavani M, Esteghamati A, Asgarani F, Khalilzadeh O, Nikzamir A, Safari R (2009) Association of oxidized lowdensity lipoprotein (LDL) and transforming growth factorbeta (TGF-b) in type 2 diabetic patients: a cross-sectional study. Transl Res 153:86-90
25. Hellmich B, Schellner M, Schatz H, Pfeiffer A (2000) Activation of transforming growth factor-beta 1 in diabetic kidney disease. Metabolism 49:353-359
26. Wang H, Deng H, Liu W (2002) The effects of paraoxonase-and oxidized low density lipoprotein on nephropathy in type-2 diabetes mellitus. Zhonghua Nei Ke Za Zhi 41:179-182
27. Ujihara N, Sakka Y, Takeda M et al (2002) Association between plasma oxidized low-density lipoprotein and diabetic nephropathy. Diabetes Res Clin Pract 58:109-114
28. Atchley DH, Lopes-Virella MF, Zheng D, Kenny D, Virella G (2002) Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy. Diabetologia 45: 1562-1571
29. Ding G, van Goor H, Ricardo SD, Orlowski JM, Diamond JR (1997) Oxidized LDL stimulates the expression of TGF-beta and fibronectin in human glomerular epithelial cells. Kidney Int 51:147-154